These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16277203)

  • 21. [Effect of mexidol on clinical and biochemical parameters of perinatal hypoxia in newborn children].
    Levitina EV
    Eksp Klin Farmakol; 2001; 64(5):34-6. PubMed ID: 11764497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Possibilities of antioxidant therapy for asthenia and cognitive deficit in elderly patients with chronic brain ischemia].
    Duma SN
    Ter Arkh; 2013; 85(12):100-5. PubMed ID: 24640678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Results of a cohort single-center randomized study of the modulating effect of the drug Mexidol in the rehabilitation of patients who suffered acute cerebral insufficiency].
    Belkin AA; Belkin VA; Vasilchenko IE; Pinchuk EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4):108-117. PubMed ID: 38676685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of alpha-lipoic acid and mexidol on neuro- and the affective status in patients at early stages of diabetic foot syndrome].
    Volchegorskiĭ IA; Alekseev MN; Volchegorskaia MI; Rassokhina LM
    Klin Med (Mosk); 2008; 86(10):52-9. PubMed ID: 19069461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.
    LeWitt P; Oakes D; Cui L
    Mov Disord; 1997 Mar; 12(2):183-9. PubMed ID: 9087976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of emoxipine, reamberine and mexidol on neuropathic symptoms and a systolic function of the left ventricular myocardium in patients with diabetes mellitus and diabetic foot syndrome].
    Volchegorskiĭ IA; Moskvicheva MG; Chashchina EN
    Ter Arkh; 2005; 77(10):10-5. PubMed ID: 16320677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of hydroxymethylethylpyridine succinate on the cardiac electrophysiological and hemodynamic parameters during experimental thoracotomy and acute myocardial ischemia].
    Kotliarov AA; Smirnov LD
    Eksp Klin Farmakol; 2004; 67(3):14-7. PubMed ID: 15341060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The neuroprotective therapy of outpatient treatment of chronic cerebral ischemia].
    Berezhnaya SV; Yakupov EZ
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):48-52. PubMed ID: 26356397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Metabolic effects of mexidol in complex treatment of chronic brain ischemia].
    Demchenko EIu; Kulakova NV; Semiglazova TA; Golovacheva AB; Borodulina EV; Udut VV
    Eksp Klin Farmakol; 2008; 71(6):13-5. PubMed ID: 19140508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mexidol potentiates antiparkinsonian effect of L-DOPA in MPTP-induced parkinsonism model].
    Kucherianu VG
    Eksp Klin Farmakol; 2001; 64(1):22-5. PubMed ID: 11544797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effectiveness of mexidol in acute pancreatitis].
    Ivanov IuV; Chudnykh SM; Mozgalin AG
    Klin Med (Mosk); 2002; 80(9):44-6. PubMed ID: 12416225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of emoxipine and mexidol in patients with chronic disorders of the digestive system and atherosclerosis of the abdominal aorta].
    Dolgushina AI
    Eksp Klin Farmakol; 2011; 74(12):11-4. PubMed ID: 22379875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, controlled trial of add-on therapy in moderate-to-severe Parkinson's disease.
    Zhao S; Cheng R; Zheng J; Li Q; Wang J; Fan W; Zhang L; Zhang Y; Li H; Liu S
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1214-8. PubMed ID: 26342560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neurometabolic therapy in secondary prevention of stroke].
    Koval'chuk VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(3):24-8. PubMed ID: 24781222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes.
    Rascol O; Fitzer-Attas CJ; Hauser R; Jankovic J; Lang A; Langston JW; Melamed E; Poewe W; Stocchi F; Tolosa E; Eyal E; Weiss YM; Olanow CW
    Lancet Neurol; 2011 May; 10(5):415-23. PubMed ID: 21482191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mexidol in combined treatment of acute pancreatitis].
    Mal'gina NV
    Khirurgiia (Mosk); 2006; (10):42-50. PubMed ID: 17159867
    [No Abstract]   [Full Text] [Related]  

  • 38. [The study of the efficacy and safety of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
    Kutashov VA; Ulyanova OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12. Vyp. 2):89-92. PubMed ID: 32207723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An analysis of mexidol efficacy in the complex treatment of patients with ischemic stroke].
    Lutskiĭ MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4 Suppl 2):57-9. PubMed ID: 20740717
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of neuroprotectors in patients with tension headaches.
    Medvedeva LA; Gnezdilov AV; Zagorul'ko OI; Syrovegin AV; Samoilova NV
    Neurosci Behav Physiol; 2007 Jun; 37(5):523-6. PubMed ID: 17505806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.